BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24613163)

  • 21. HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds.
    Gómara MJ; Galatola R; Gutiérrez A; Gimeno MC; Gatell JM; Sánchez-Merino V; Yuste E; Haro I
    Curr Med Chem; 2014; 21(2):238-50. PubMed ID: 24083612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors.
    Chen X; Ding L; Tao Y; Pannecouque C; De Clercq E; Zhuang C; Chen FE
    Eur J Med Chem; 2020 Sep; 202():112549. PubMed ID: 32712537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors.
    Li J; Jiang X; Dick A; Prakash Sharma P; Chen CH; Rathi B; Kang D; Wang Z; Ji X; Lee KH; Cocklin S; Liu X; Zhan P
    Bioorg Med Chem; 2021 Oct; 48():116414. PubMed ID: 34562701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid.
    Kortagere S; Madani N; Mankowski MK; Schön A; Zentner I; Swaminathan G; Princiotto A; Anthony K; Oza A; Sierra LJ; Passic SR; Wang X; Jones DM; Stavale E; Krebs FC; Martín-García J; Freire E; Ptak RG; Sodroski J; Cocklin S; Smith AB
    J Virol; 2012 Aug; 86(16):8472-81. PubMed ID: 22647699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between D- and L-cysteine at positions i and i+3, respectively, derived from HIV-1 gp41 C-peptide.
    Lee MK; Kim HK; Lee TY; Hahm KS; Kim KL
    Exp Mol Med; 2006 Feb; 38(1):18-26. PubMed ID: 16520549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors.
    Sun L; Zhang X; Xu S; Huang T; Song S; Cherukupalli S; Zhan P; Liu X
    Eur J Med Chem; 2021 May; 217():113380. PubMed ID: 33751981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical optimization of macrocyclic HIV-1 inactivators for improving potency and increasing the structural diversity at the triazole ring.
    Rashad AA; Acharya K; Haftl A; Aneja R; Dick A; Holmes AP; Chaiken I
    Org Biomol Chem; 2017 Sep; 15(37):7770-7782. PubMed ID: 28770939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
    Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
    J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
    Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
    Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and evaluation of peptide libraries as potential anti-HIV compounds, via inhibition of gp120/cell membrane interactions, using the gp120/cd4/fab17 crystal structure.
    Boussard C; Doyle VE; Mahmood N; Klimkait T; Pritchard M; Gilbert IH
    Eur J Med Chem; 2002 Nov; 37(11):883-90. PubMed ID: 12446047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The active core in a triazole peptide dual-site antagonist of HIV-1 gp120.
    Umashankara M; McFadden K; Zentner I; Schön A; Rajagopal S; Tuzer F; Kuriakose SA; Contarino M; Lalonde J; Freire E; Chaiken I
    ChemMedChem; 2010 Nov; 5(11):1871-9. PubMed ID: 20677318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel compounds containing multiple guanide groups that bind the HIV coreceptor CXCR4.
    Wilkinson RA; Pincus SH; Shepard JB; Walton SK; Bergin EP; Labib M; Teintze M
    Antimicrob Agents Chemother; 2011 Jan; 55(1):255-63. PubMed ID: 20937786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HIV-1 activity of a tripodal receptor that recognizes mannose oligomers.
    Rivero-Buceta E; Carrero P; Casanova E; Doyagüez EG; Madrona A; Quesada E; Peréz-Pérez MJ; Mateos R; Bravo L; Mathys L; Noppen S; Kiselev E; Marchand C; Pommier Y; Liekens S; Balzarini J; Camarasa MJ; San-Félix A
    Eur J Med Chem; 2015 Dec; 106():132-43. PubMed ID: 26540494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of anti-HIV peptides based on a viral capsid protein.
    Mizuguchi T; Ohashi N; Matsumoto D; Hashimoto C; Nomura W; Yamamoto N; Murakami T; Tamamura H
    Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27428649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-natural peptide triazole antagonists of HIV-1 envelope gp120.
    Kamanna K; Aneja R; Duffy C; Kubinski P; Rodrigo Moreira D; Bailey LD; McFadden K; Schön A; Holmes A; Tuzer F; Contarino M; Freire E; Chaiken IM
    ChemMedChem; 2013 Feb; 8(2):322-8. PubMed ID: 23239505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment.
    Tsuji K; Wang R; Kobayakawa T; Owusu KB; Fujino M; Kaneko M; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2021 Jan; 30():115923. PubMed ID: 33316719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel structures of self-associating stapled peptides.
    Bhattacharya S; Zhang H; Cowburn D; Debnath AK
    Biopolymers; 2012 May; 97(5):253-64. PubMed ID: 22170623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
    Wang L; Casey MC; Vernekar SKV; Do HT; Sahani RL; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Eur J Med Chem; 2020 Aug; 200():112427. PubMed ID: 32438252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyvalent side chain peptide-synthetic polymer conjugates as HIV-1 entry inhibitors.
    Danial M; Root MJ; Klok HA
    Biomacromolecules; 2012 May; 13(5):1438-47. PubMed ID: 22455441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suitable fusion of N-terminal heptad repeats to achieve covalently stabilized potent N-peptide inhibitors of HIV-1 infection.
    Lai W; Wang C; Yan J; Liu H; Zhang W; Lin B; Xi Z
    Bioorg Med Chem; 2020 Feb; 28(4):115214. PubMed ID: 31932193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.